Elan Subpoenaed Over Drug Disclosures

Elan Corp. said Tuesday that it received a subpoena from the U.S. Securities and Exchange Commission seeking information related to disclosures last year about the Ireland-based drug maker’s multiple-sclerosis drug Tysabri and an experimental drug for

Leave a Reply